Walgreens CEO Roz Brewer steps down after more than 2 years in the role

Walgreens CEO Roz Brewer steps down after more than 2 years in the role


Rosalind “Roz” Brewer

Jason Redmond | Afp | Getty Images

Walgreens Boots Alliance said Friday that Roz Brewer had stepped down as the company’s chief executive.

She also left the company’s board, effective Thursday. The decision was mutual, according to a news release.

Brewer and Walgreens were in a rough patch leading up to Friday’s announcement. Walgreens shares are down more than 32% this year as of Thursday’s close, as the company has struggled with a drop in demand for Covid testing and vaccines. In June, the company reported fiscal third quarter earnings that missed Wall Street expectations for the first time since July 2020. It also slashed its profit guidance for the year.

Walgreens said it is searching for a new CEO. In the meantime, Ginger Graham, the lead independent director, will work as interim chief.

A veteran of Walmart and Starbucks, Brewer had led Walgreens since March 2021. During her brief tenure, which included a sizable stretch of the Covid pandemic, the company had pursued a transition that would position Walgreens more as a health care company than a pharmacy chain.

“I am confident that WBA is on track to be a leading consumer-centric healthcare company, serving thousands of communities across the country, especially those that need access to healthcare the most,” Brewer said in Friday’s announcement.

This is breaking news. Please check back for updates.



Source

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More
Patient advocacy groups urge U.S. court to halt overseas prescription drug operations
Health

Patient advocacy groups urge U.S. court to halt overseas prescription drug operations

In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York. Spencer Platt | Getty Images News | Getty Images A coalition of patient advocacy groups is urging a federal court to halt the practices of third-party companies that buy drugs from countries outside the FDA-regulated […]

Read More
CNBC launches CNBC Cures to help 30 million Americans with rare diseases
Health

CNBC launches CNBC Cures to help 30 million Americans with rare diseases

Thirty million. It’s a big number. Maybe not in the context of business news, where we usually talk about company valuations that are in the billions, or even trillions. But when we’re talking about people, 30 million is a very big number.  Thirty million is the number of people that the National Organization of Rare […]

Read More